Lanman Xu
Impact in
- Hepatology top 5%
- Liver Diseases and Immunity
- Liver physiology and pathology
- Genetics top 5%
- Mesenchymal stem cell research
Papers in
- Hepatology 17
- Liver Diseases and Immunity 10
- Liver Disease and Transplantation 4
- Liver physiology and pathology 3
- Genetics 6
- Mesenchymal stem cell research 6
- Co-authors
- Yongping Chen (21 shared papers)Da‐Zhi Chen (19 shared papers)En-De Hu (7 shared papers)Feng‐Bin Lu (7 shared papers)Jinlu Wu (6 shared papers)Zhuo Lin (13 shared papers)Ming‐Hua Zheng (5 shared papers)Yong‐Ping Chen (6 shared papers)
- Journals
- Immunology Letters (2 papers)Journal of Cellular and Molecular Medicine (2 papers)European Journal of Pharmacology (2 papers)Frontiers in Physiology (2 papers)Oxidative Medicine and Cellular Longevity (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Lanman Xu
35 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 79
- Hepatology 212
- Genetics 174
- Epidemiology 252
- Molecular Biology 441
- Pathology and Forensic Medicine 85
Countries citing papers authored by Lanman Xu
This map shows the geographic impact of Lanman Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanman Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanman Xu more than expected).
Fields of papers citing papers by Lanman Xu
This network shows the impact of papers produced by Lanman Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanman Xu. The network helps show where Lanman Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lanman Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 198 | |
| 2 | 2018 | 121 | |
| 3 | 2015 | 111 | |
| 4 | 2014 | 93 | |
| 5 | 2017 | 84 | |
| 6 | 2018 | 83 | |
| 7 | 2018 | 80 | |
| 8 | 2016 | 70 | |
| 9 | 2019 | 62 | |
| 10 | 2021 | 51 | |
| 11 | 2022 | 40 | |
| 12 | 2017 | 35 | |
| 13 | Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway. | 2014 | 33 |
| 14 | 2019 | 30 | |
| 15 | Bone marrow-derived mesenchymal stem cells inhibits hepatocyte apoptosis after acute liver injury. | 2015 | 29 |
| 16 | 2016 | 29 | |
| 17 | 2024 | 28 | |
| 18 | 2014 | 22 | |
| 19 | 2019 | 22 | |
| 20 | 2016 | 20 |
About Lanman Xu
Lanman Xu is a scholar working on Hepatology, Genetics, Pathology and Forensic Medicine, Pharmacology and Epidemiology, having authored 39 papers that have together received 1.4k indexed citations. Recurring topics across this work include Liver Diseases and Immunity (10 papers), Alcohol Consumption and Health Effects (7 papers), Mesenchymal stem cell research (6 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Probiotics and Fermented Foods (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Liver Disease and Transplantation (4 papers) and Liver physiology and pathology (3 papers). The work is most often cited by research in Hepatology (212 citations), Genetics (174 citations), Epidemiology (252 citations), Molecular Biology (441 citations) and Pathology and Forensic Medicine (85 citations). Lanman Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yongping Chen, Da‐Zhi Chen, En-De Hu, Feng‐Bin Lu, Jinlu Wu, Zhuo Lin, Ming‐Hua Zheng, Yong‐Ping Chen, Yuewen Gong and Xiaoya Jin. Their work appears in journals such as Immunology Letters, Journal of Cellular and Molecular Medicine, European Journal of Pharmacology, Frontiers in Physiology and Oxidative Medicine and Cellular Longevity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.